United States · FDA National Drug Code directory
Sitagliptin and Metformin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-5801_a0fcdc08-0afc-4912-a126-3efea6bc8c61
- Product NDC
- 0781-5801
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sitagliptin and Metformin Hydrochloride
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251202
- Source listing expiry
- 20271231
Source-listed ingredients
- SITAGLIPTIN PHOSPHATE — 50 mg/1
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (0781-5801-05) · 0781-5801-05
- 60 TABLET, FILM COATED in 1 BOTTLE (0781-5801-60) · 0781-5801-60
- 180 TABLET, FILM COATED in 1 BOTTLE (0781-5801-71) · 0781-5801-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →